What Haemoview Diagnostics does

Haemoview Diagnostics Pty Ltd is an Australia-based, privately held specialty medical device distributor operating exclusively in the Australia and New Zealand (ANZ) region. Founded in 2008 and headquartered in Milton, Queensland, the company (1-10 employees) focuses on viscoelastic testing and haemostasis diagnostics, distributing four core platforms: MultiClot (a six-channel viscoelastic whole-blood coagulation analyzer with proprietary reagent tip technology developed by partner Apiro, launching in ANZ in 2026), ClotPro (a viscoelastometry platform with eight assays covering coagulation activation through fibrinolysis and DOAC monitoring), Multiplate (multiple electrode aggregometry for platelet function testing), and DOASENSE (a point-of-care urine dipstick for direct oral anticoagulant detection in approximately 10 minutes).

The company serves clinicians in ICUs, operating theatres, and emergency departments, as well as research institutions and laboratories across ANZ. Revenue is generated through one-time equipment sales, recurring reagent and consumable supply (cups and pins, reagent tips, test cells, DOASENSE strips, QC materials), and training/education services. Pricing is quote-based with small-order handling charges and flat regional delivery rates, indicating a transactional B2B distribution model with workflow-integration-driven switching costs.

Haemoview's go-to-market is sales-led and direct: the company reaches healthcare professionals through its website, LinkedIn presence, email marketing, clinical evidence publications, and structured online training modules. Its primary differentiation stems from exclusive ANZ distribution rights for the MultiClot and ClotPro platforms and an assay menu (including dedicated DOAC and antifibrinolytic tests) that competing fixed-cartridge viscoelastic systems in the region cannot replicate.

Name

Haemoview Diagnostics

Legal name

Haemoview Diagnostics Pty Ltd

Website

https://haemoview.com.au

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Haemoview Diagnostics is an ANZ specialty distributor of viscoelastic testing and haemostasis diagnostic platforms (MultiClot, ClotPro, Multiplate, DOASENSE), serving hospitals, emergency departments, and research laboratories across Australia and New Zealand.

Ownership category

akta.pro rank

Product category

Haemostasis Diagnostics

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)

akta.pro secondary industries

Hematology & Coagulation Laboratories (HLAFAMAC), Clinical Chemistry, Hematology & Coagulation Testing (Trial Support) (HLAGAEAE)

Keywords

• Viscoelastic testing
• Haemostasis diagnostics
• Coagulation analyzers
• Platelet function testing
• DOAC point-of-care testing

Headquarters

HQ city

Brisbane

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Device and Reagent Sales: Haemoview generates revenue through the sale of viscoelastic testing equipment, reagents, and consumables to healthcare facilities across Australia and New Zealand.
2. Reagent and Consumable Supplies: Recurring revenue from reagent cartridges, test cells, cups and pins, and quality control materials. Small pack sizes of 10 cartridges support cost-effective testing across clinical and research settings.
3. Training and Education Services: Online training modules for MultiClot, DOASENSE, and Multiplate products provided to healthcare professionals, with structured modules for device operation and clinical interpretation.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Haemoview Diagnostics distributes and supports advanced viscoelastic testing and haemostasis diagnostic platforms for healthcare facilities across Australia and New Zealand. Its portfolio includes MultiClot (six-channel whole-blood viscoelastic analyzer), ClotPro (multi-assay viscoelastometry), Multiplate (platelet function testing), and DOASENSE (point-of-care urine DOAC dipstick), along with associated assay reagents, consumables, and clinician training.

Product overview

Haemoview Diagnostics is ANZ's specialist in viscoelastometry and haemostasis diagnostics, distributing and supporting a portfolio of coagulation testing platforms. The core product ecosystem includes MultiClot (a six-channel viscoelastic whole-blood coagulation analyzer developed by Apiro with innovative reagent tip technology) and ClotPro (a viscoelastometry platform offering an industry-leading test menu with eight established assays: EX, FIB, AP, IN, HI, RVV, TPA, and ECA covering coagulation activation, clot formation, clot stability, fibrinolysis, and DOAC monitoring). Multiplate provides platelet function testing via multiple electrode aggregometry. DOASENSE enables rapid point-of-care urine-based DOAC detection in approximately 10 minutes. The company also provides comprehensive consumables (cups and pins, test strips, test cells), quality control materials (QC-1, QC-2), and structured online training modules for healthcare professionals across Australia and New Zealand.

Differentiator

Problem solved

Functional benefit

Products and services

• MultiClot Viscoelastic whole-blood coagulation analyzer using cup and pin technology with Elastic Motion Thromboelastography, six independent channels with high-sensitivity capacitive signal detection, requiring only 340 µL of blood per test, and innovative reagent tip technology with auto-reconstituting dry reagent carriers.
• ClotPro Viscoelastometry platform providing multiple assay options (EX, FIB, AP, IN, HI, RVV, TPA, ECA) for comprehensive coagulation assessment including DOAC monitoring and antifibrinolytic detection. Supports both clinical and research environments.
• Multiplate Platelet function testing system using multiple electrode aggregometry with various test cells including ADP, ASPI (arachidonic acid), TRAP (thrombin), PGE (prostaglandin E1), and GPIIb/IIIa for comprehensive platelet function assessment.
• DOASENSE Point-of-care urine dipstick test for rapid detection of clinically significant Direct Oral Anticoagulant (DOAC) levels. Provides results in approximately 10 minutes at the bedside with no blood draw required and 95% correlation with plasma DOAC levels.
• ClotPro Assay Reagents (EX, FIB, AP, IN, HI, RVV, TPA, ECA) Suite of ClotPro assay reagents: EX-Assay (extrinsic pathway), FIB-Assay (functional fibrinogen), AP-Assay (fibrinolysis inhibition with tranexamic acid), IN-Assay (intrinsic pathway with heparin sensitivity), HI-Assay (intrinsic pathway with heparin neutralisation), RVV-Assay (factor Xa inhibitor/DOAC assessment), TPA-Assay (fibrinolysis resistance/TXA effects), and ECA-Assay (dabigatran detection).
• Cup & Pin Consumables Single cup and pin consumables with durable polymer design, surface treatment for hemocompatibility, and consistent torque transfer for viscoelastometry testing.
• DOASENSE Test Strips Urine test strips for detection of direct oral anticoagulants at point-of-care.
• DOASENSE Controls Control urine materials for verification of DOASENSE test performance.
• Multiplate Test Cells Test cell consumables for platelet function analysis using multiple electrode aggregometry.
• Quality Control Materials (QC-1, QC-2) Quality control materials based on normal plasma for internal quality control of reagents: QC-1 (normal plasma) and QC-2 (normal plasma with addition of anticoagulant).
• Online Training and Education Modules Structured online training modules covering foundation, advanced, and clinical interpretation of MultiClot, DOASENSE, and Multiplate products, delivered to healthcare professionals.

Quantifiable outcome

• DOASENSE provides results in approximately 10 minutes vs 45-60 minutes for standard plasma DOAC testing
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• ApirocoreStrategic or Co-development PartnerApiro developed the MultiClot system through years of international collaboration with clinical experts and scientists worldwide. Haemoview Diagnostics serves as the exclusive distributor of MultiClot and ClotPro systems in Australia and New Zealand. The partnership represents a landmark advancement in viscoelastometry with an industry-leading test menu.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Haemonetics: Haemonetics owns the TEG (Thromboelastography) portfolio, the global incumbent in viscoelastic hemostasis testing. It is directly comparable as a supplier of viscoelastic analyzers and reagents used in bleeding and thrombosis management, competing with MultiClot and ClotPro.
• Werfen: Werfen manufactures the ROTEM/ROTEM sigma viscoelastic testing systems, a direct competitor to MultiClot and ClotPro in whole-blood coagulation analysis. Comparable as a global supplier of viscoelastic diagnostic platforms and reagents to hospitals and reference laboratories.
• Diagnostica Stago: Diagnostica Stago is a specialist coagulation diagnostics company offering hemostasis analyzers and reagents. Comparable as a focused supplier of coagulation and hemostasis testing solutions, overlapping with Haemoview's clinical customer base in hospital labs.

Emerging players

• EKF Diagnostics: EKF Diagnostics offers point-of-care and clinical chemistry diagnostics including coagulation-related products. Comparable as a smaller, specialized diagnostics vendor with partial overlap in POC and clinical chemistry testing.
• Precision BioLogic: Precision BioLogic develops coagulation reagents and quality controls used in hemostasis laboratories. Comparable as a niche supplier of coagulation diagnostic reagents and QC materials relevant to Haemoview's consumables portfolio.
• Helena Laboratories: Helena Laboratories supplies coagulation and hemostasis testing instruments, reagents, and consumables to clinical labs. Comparable as a specialist competitor in coagulation diagnostics targeting similar hospital laboratory customers.

Broad incumbents

• Abbott: Abbott's i-STAT and broader diagnostics portfolio includes point-of-care coagulation testing (e.g., INR). Comparable as a broad incumbent offering overlapping hemostasis diagnostics as part of a much wider diagnostic menu serving similar hospital customers.
• Sysmex Corporation: Sysmex is a global leader in hematology and hemostasis diagnostics with analyzers (e.g., CS- and XN-series) used in clinical labs. Comparable as a broad incumbent in adjacent hematology/coagulation testing serving overlapping hospital laboratory customers.
• Siemens Healthineers: Siemens Healthineers provides coagulation and hemostasis analyzers (e.g., Sysmex CS systems historically) within its broader diagnostics portfolio. Comparable as a broad incumbent serving the same hospital laboratories with overlapping coagulation testing capabilities.
• Roche Diagnostics: Roche Diagnostics offers coagulation testing solutions (e.g., cobas t series) as part of its central laboratory diagnostics business. Comparable as a broad incumbent supplying hospital and reference labs with overlapping coagulation diagnostic capabilities.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/haemoview-diagnostics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haemoview Diagnostics